Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07494578
Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View on ClinicalTrials.gov
Summary
This study will enroll patients with metastatic colorectal cancer treated with the combination of Trifluridine/Tipiracile and Bevacizumab across 15 italian centers.
Official title: Multicenter Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in the Treatment of Patients With Metastatic Colorectal Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2025-07-01
Completion Date
2027-08-01
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
Fluoropyrimidine
Treatment with fluoropyrimidines and bevacizumab
Locations (1)
Policlinico Universitario Agostino Gemelli
Rome, Lazio, Italy